Condition: Aortic Stenosis · Sponsor: University Hospital, Basel, Switzerland
This is a multi-centric, open-label, randomized trial to evaluate the safety and efficacy of temporary discontinuation of beta-blocker treatment in patients undergoing transcatheter aortic valve replacement.
This description comes directly from the study's public registry record.
Nicole Gilgen, Dr. med. · +41 61 328 74 23 · Nicole.Gilgen@usb.ch
Thomas Nestelberger, PD Dr. · +41 61 328 74 74 · thomas.nestelberger@usb.ch
Always discuss trial participation with your own doctor first.
| Medical University of Graz | Graz, Austria | Recruiting |
| University Hospital Salzburg | Salzburg, Austria | Recruiting |
| University Medical Center Freiburg | Bad Krozingen, Germany | Recruiting |
| Kerckhoff-Klinik GmbH | Bad Nauheim, Germany | Recruiting |
| Herz- und Diabeteszentrum NRW Universitätsklinik | Bad Oeynhausen, Germany | Recruiting |
| Universitätsklinikum Giessen und Marburg GmbH | Giessen, Germany | Recruiting |
| Universitätsklinikum Schleswig-Holstein AöR | Kiel, Germany | Recruiting |
| University Hospital Basel | Basel, Switzerland | Recruiting |
| Inselspital, Bern University Hospital | Bern, Switzerland | Recruiting |
| Geneva University Hospitals | Geneva, Switzerland | Recruiting |
| University Hospital of Zürich | Zurich, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06472934